Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Sales | 368 | 389 | 199 | 839 | 52 |
| Cost of Goods | 13 | 14 | N/A | -4 | 28 |
| Gross Profit | 355 | 375 | 199 | 843 | 24 |
| Operating Expenses | 6,501 | 8,352 | 33,451 | 30,232 | 20,570 |
| Operating Income | -6,133 | -7,963 | -33,252 | -29,393 | -20,518 |
| Other Income | -622 | 274 | -1,203 | 897 | 1,017 |
| Pre-tax Income | -6,755 | -7,689 | -34,455 | -28,496 | -19,501 |
| Net Income Continuous | -6,755 | -7,689 | -34,455 | -28,532 | -19,501 |
| Net Income Discontinuous | -86 | -8 | -81 | -729 | -27 |
| Net Income | $-6,841 | $-7,697 | $-34,536 | $-29,261 | $-19,528 |
| EPS Basic Total Ops | -0.15 | -0.17 | -0.79 | -0.67 | -0.45 |
| EPS Basic Continuous Ops | -0.15 | -0.17 | -0.79 | -0.65 | -0.45 |
| EPS Basic Discontinuous Ops | 0.00 | 0.00 | 0.00 | -0.02 | 0.00 |
| EPS Diluted Total Ops | -0.15 | -0.17 | -0.79 | -0.67 | -0.45 |
| EPS Diluted Continuous Ops | -0.15 | -0.17 | -0.79 | -0.65 | -0.45 |
| EPS Diluted Discontinuous Ops | 0.00 | 0.00 | 0.00 | -0.02 | 0.00 |
| EBITDA(a) | $-6,114 | $-7,931 | $-33,218 | $-29,359 | $-20,506 |